demonstrated that the intratumoral microbiota modulates the pro-tumor/anti-tumor balance within the TIME through a STING-IFN I-dependent mechanism, reprogramming intratumoral macrophages to promote antitumor immunity and the efficacy of ICB therapy (Lam et al., 2021). Here, STING1 is linked to neoplasm.